Experienced in Glomerulonephritis

Foteini Filippidou-Moschovaki

Graz, AT 
Experienced in Glomerulonephritis
Graz, AT 
OverviewLocationsClinical Research

Overview

Foteini Filippidou-Moschovaki practices in Graz, Austria. Filippidou-Moschovaki is rated as an Experienced expert by MediFind in the treatment of Glomerulonephritis. Their top areas of expertise are Tubular Aggregate Myopathy, X-Linked Myotubular Myopathy, Congenital Fiber-Type Disproportion, and Centronuclear Myopathy.

Their clinical research consists of co-authoring 10 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Glomerulonephritis.

Locations

Graz, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Total Publications

Lack of myotubularin phosphatase activity is the main cause of X-linked myotubular myopathy.
Lack of myotubularin phosphatase activity is the main cause of X-linked myotubular myopathy.
Journal: JCI insight
Published: November 15, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Filippidou-Moschovaki's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile